Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasm Metastasis 1Hypertension 1Essential Hypertension 1

Interventions

relacorilant 5Hydrochlorothiazide 2Amlodipine 2sacubitril and valsartan sodium hydrate drug combination 1pembrolizumab 1fimasartan 1cediranib 1aliskiren 1Osilodrostat 1Enalapril 1Amlodipine, Valsartan Drug Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Hypertension × aliskiren × Clear all
NCT01151410 2016-03-07

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age

Novartis

Phase 3 Completed
208 enrolled 10 charts

Essential Hypertension, Hypertension, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡